Related Experiment Video
Updated: Aug 25, 2025

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
Published on: July 3, 2025
Bibliometric analysis of fibroblast growth factor 21 research over the period 2000 to 2021
Qin-Ying She1, Li-Juan Li1, Ming-Hong Liu1
1Department of Nephrology, The Fifth Affiliated Hospital, Southern Medical University, Guangzhou, China.
Abstract:
Background: Fibroblast growth factor 21 (FGF-21) is an evolutionarily conserved protein that plays multiple roles in metabolic regulation. Over the past two decades, numerous studies have deepened our understanding of its various functions and its pharmacological value. Nevertheless, most clinical trials have not achieved the desired results, which raises issues regarding its clinical value. In this bibliometric analysis, we evaluated the state of FGF-21 research over the last 20 years and identified important topics, achievements, and potential future directions. Methods: Publications related to FGF-21 were collected from the Web of Science Core Collection-Science Citation Index Expanded. HistCite, VOSviewer, and CiteSpace were used for bibliometric analysis and visualization, including the analysis of annual publications, leading countries, active institutions and authors, core journals, co-cited references, and keywords. Results: Altogether, 2,490 publications related to FGF-21 were obtained. A total of 12,872 authors from 2,628 institutions in 77 countries or regions reported studies on FGF-21. The United States of America was the most influential country in FGF-21 research. Alexei Kharitonenkov, Steven A. Kliewer, and David J. Mangelsdorf were the most influential scholars, and endocrinology journals had a core status in the field. The physiological roles, clinical translation, and FGF-21-based drug development were the main topics of research, and future studies may concentrate on the central effects of FGF-21, FGF-21-based drug development, and the effects of FGF-21 on non-metabolic diseases. Conclusion: The peripheral metabolic effects of FGF-21, FGF-21-based drug development, and translational research on metabolic diseases are the three major topics in FGF-21 research, whereas the central metabolic effects of FGF-21 and the effects of FGF-21 on metabolic diseases are the emerging trends and may become the following hot topics in FGF-21 research.
Insights
Fibroblast growth factor 21 (FGF-21) research shows peripheral metabolic effects and drug development are key topics. Emerging trends include central FGF-21 effects and non-metabolic disease impacts.
Area of Science:
- Metabolic Regulation
- Endocrinology
- Pharmacology
Background:
- Fibroblast growth factor 21 (FGF-21) is a key metabolic regulator with significant pharmacological potential.
- Despite extensive research, clinical trial outcomes for FGF-21 have been inconsistent, prompting further investigation into its therapeutic value.
Purpose of the Study:
- To conduct a bibliometric analysis of FGF-21 research over the past 20 years.
- To identify key research topics, influential contributors, and emerging trends in the field.
- To evaluate the current state and future directions of FGF-21 research.
Main Methods:
- Collected 2,490 publications on FGF-21 from the Web of Science Core Collection (Science Citation Index Expanded).
- Utilized HistCite, VOSviewer, and CiteSpace for bibliometric analysis and visualization.
- Analyzed publication trends, leading countries, institutions, authors, journals, and keywords.
Main Results:
- Research on FGF-21 has involved 12,872 authors from 2,628 institutions across 77 countries.
- The United States led in FGF-21 research, with Alexei Kharitonenkov, Steven A. Kliewer, and David J. Mangelsdorf as highly influential scholars.
- Key research areas included physiological roles, clinical translation, and FGF-21 drug development, with endocrinology journals being central.
Conclusions:
- Peripheral metabolic effects, drug development, and translational research on metabolic diseases are the primary focuses in FGF-21 studies.
- Future research is expected to concentrate on central FGF-21 effects and its impact on non-metabolic diseases, representing emerging trends.
Related Concept Videos
Introduction to Fibroblasts
Fibronectins Connect Cells with ECM
Both proteoglycans and collagen are attached to fibronectin proteins, which, in turn, are attached to integrin proteins. These integrin proteins interact with transmembrane...
Regulation of Angiogenesis and Blood Supply
Mitogens and the Cell Cycle
TGF - β Signaling Pathway

